Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07306078 · ClinicalTrials.gov registry record · Phase 2
Methylphenidate and Response to Alcohol Cues
A Phase 2 study, sponsored by University of Florida.
- Not yet
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT07306078 is a Phase 2 study that has not yet begun recruiting, run by University of Florida. The registered enrollment target is 50 participants.
The verdict
NCT07306078, a Phase 2 study, has not yet begun recruiting, sponsored by University of Florida.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether changes in attention levels related to taking a single dose of a medication called methylphenidate, also known as Ritalin, affects responses to alcohol cues. The study will observe the effects of methylphenidate or a placebo on neural and craving responses to alcohol cues through fMRI and behavioral testing. Participants will be involved in one remote and two in-person sessions.
Interventions
- DRUG Methylphenidate Pill
- OTHER Placebo Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-05 |
| Est. Completion | 2028-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07306078
The ClinicalTrials.gov registry entry for NCT07306078 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methylphenidate Pill is the first listed.
NCT07306078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07306078 about?
NCT07306078 is a clinical study titled "Methylphenidate and Response to Alcohol Cues". The purpose of this study is to determine whether changes in attention levels related to taking a single dose of a medication called methylphenidate, also known as Ritalin, affects responses to alcohol cues. The study will observe the effects of methylphenidate or a placebo on neural and craving res...
What is the current status of trial NCT07306078?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2026-05. Estimated completion is 2028-04.
What interventions are being tested in trial NCT07306078?
The interventions under investigation include: Methylphenidate Pill (DRUG), Placebo Pill (OTHER).
Who is sponsoring clinical trial NCT07306078?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.